CervoMed Inc.
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 177.1% | -101.9% | -60.7% | -66.9% | -250.2% | -372.4% | -203.1% | -370.6% | -2,004.3% | -75,357.5% | – | – | -8,444.9% | |
| 7.2% | 6.6% | 9.3% | 17.6% | 14.0% | 15.6% | 18.8% | 28.3% | 90.4% | 3,423.5% | – | – | 393.0% | |
| 105.8% | -13.7% | 37.2% | -3.8% | 5.8% | -60.1% | 46.4% | -29.5% | 369.3% | 15,573.2% | – | – | 460.9% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | 0.0% | |
| -819.1% | – | – | -1,233.5% | 134.1% | 430.5% | 281.5% | -14.5% | 2,350.5% | 61,583.4% | – | – | 7,000.6% | |
| 736.7% | -3.7% | – | 1,411.1% | -0.7% | 0.0% | 0.0% | 261.1% | 0.0% | 0.0% | – | – | 5,713.0% | |
| -299.8% | -105.7% | -60.7% | 110.7% | -116.8% | 58.1% | 78.4% | -124.1% | 346.2% | -13,774.1% | – | – | 4,268.7% | |
| 177.1% | -101.9% | -60.7% | -66.9% | -250.2% | -372.4% | -203.1% | -370.6% | -2,004.3% | -75,357.6% | – | – | -8,444.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.